Anupam Rasayan India (NSE:ANURAS) Research & Development: ₹0 Mil (TTM As of Dec. 2025)


NSE:ANURAS Anupam Rasayan India Ltd NSE:ANURAS
87 GF Score
Price ₹1,269.90
GF Value ₹1,355.25
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Anupam Rasayan India Research & Development?

Anupam Rasayan India NSE:ANURAS -0.30% 87 Research & Development is ₹0 Mil as of Dec. 2025. GuruFocus rates NSE:ANURAS with a GF Score™ of 87/100 and a GF Value™ of ₹1,355.25 (Fairly Valued). The stock has 5 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Anupam Rasayan India's Research & Development for the three months ended in Dec. 2025 was ₹0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was ₹0 Mil.


Anupam Rasayan India  (NSE:ANURAS) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Anupam Rasayan India Research & Development Related Terms


Anupam Rasayan India Research & Development Historical Data

* Premium members only.

The historical data trend for Anupam Rasayan India's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Anupam Rasayan India Research & Development Chart

Anupam Rasayan India Annual Data
Trend Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Research & Development
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Anupam Rasayan India Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
NSE:ANURAS
87GF Score
Anupam Rasayan India Ltd NSE:ANURAS
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Anupam Rasayan India Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of ₹0 Mil mean?
Anupam Rasayan India (NSE:ANURAS) has a Research & Development of ₹0 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Anupam Rasayan India and its competitors.
Is Anupam Rasayan India's Research & Development too high?
Anupam Rasayan India's current Research & Development is ₹0 Mil. Overall, Anupam Rasayan India has a GF Score™ of 87/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Anupam Rasayan India's Research & Development compare to LIN and SHW?
Anupam Rasayan India's Research & Development of ₹0 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Chemicals company?
A good Research & Development depends on the Chemicals industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Anupam Rasayan India and its competitors. Anupam Rasayan India's current Research & Development is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Anupam Rasayan India stock overvalued right now?
Based on GuruFocus' analysis, Anupam Rasayan India (NSE:ANURAS) is currently considered Fairly Valued. The stock's GF Value™ is ₹1,355.25, compared to a current price of ₹1,269.90 — trading 6.3% below its estimated fair value. The current Research & Development is ₹0 Mil. Anupam Rasayan India's overall GF Score™ is 87/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Anupam Rasayan India (NSE:ANURAS), the current Research & Development is ₹0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Anupam Rasayan India (NSE:ANURAS) Overvalued in 2026?

Based on GuruFocus' analysis, Anupam Rasayan India stock appears to be undervalued. The current stock price of ₹1,269.90 is trading 6.3% below its estimated GF Value™ of ₹1,355.25. GuruFocus considers Anupam Rasayan India to be Fairly Valued.

Key valuation signals for NSE:ANURAS:

  • Research & Development: ₹0 Mil
  • GF Value™: ₹1,355.25 vs. price of ₹1,269.90 (6.3% below fair value)
  • GF Score™: 87/100 with 5 warning signs

No single metric tells the full story. See the NSE:ANURAS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Anupam Rasayan India Business Description

Other Exchanges 543275:India
Address Dumas Road, 10th Floor, Icon Rio, Behind Icon Business Centre, Surat, GJ, IND, 395007
Anupam Rasayan India Ltd is engaged in the custom synthesis and manufacturing of specialty chemicals in India. The company's business verticals are life science-related specialty chemicals comprising products related to agrochemicals, personal care and pharmaceuticals, and other specialty chemicals, comprising specialty pigment and dyes, and polymer additives. The company operates only in one revenue segment which is the Manufacturing of industrial chemicals. Geographically, it derives maximum revenue from India and the rest from Japan, Europe, Singapore, China, North America, and the Rest of the world.
87GF Score

Get the complete analysis for NSE:ANURAS

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,269.90
Price
₹1,355.25
GF Value